JP2024539138A5 - - Google Patents

Info

Publication number
JP2024539138A5
JP2024539138A5 JP2024523623A JP2024523623A JP2024539138A5 JP 2024539138 A5 JP2024539138 A5 JP 2024539138A5 JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024539138 A5 JP2024539138 A5 JP 2024539138A5
Authority
JP
Japan
Prior art keywords
sequence
peptide
amino acids
peptide according
side chains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539138A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/079429 external-priority patent/WO2023067167A1/en
Publication of JP2024539138A publication Critical patent/JP2024539138A/ja
Publication of JP2024539138A5 publication Critical patent/JP2024539138A5/ja
Pending legal-status Critical Current

Links

JP2024523623A 2021-10-22 2022-10-21 多価効果を持つペプチド Pending JP2024539138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21204274.1 2021-10-22
EP21204274 2021-10-22
PCT/EP2022/079429 WO2023067167A1 (en) 2021-10-22 2022-10-21 Peptides with multivalent effects

Publications (2)

Publication Number Publication Date
JP2024539138A JP2024539138A (ja) 2024-10-28
JP2024539138A5 true JP2024539138A5 (cg-RX-API-DMAC7.html) 2025-11-11

Family

ID=78592450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523623A Pending JP2024539138A (ja) 2021-10-22 2022-10-21 多価効果を持つペプチド

Country Status (7)

Country Link
US (1) US20250313820A1 (cg-RX-API-DMAC7.html)
EP (1) EP4419664A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024539138A (cg-RX-API-DMAC7.html)
CN (1) CN118202043A (cg-RX-API-DMAC7.html)
AU (1) AU2022369065A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233135A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023067167A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223868A1 (en) * 2023-04-26 2024-10-31 In2Cure Ab Peptides with multivalent effects for topical use
CN121793993A (zh) 2023-09-06 2026-04-03 英图库尔公司 具有抗炎和/或抗微生物特性的材料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009526046A (ja) * 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
US20230127258A1 (en) * 2019-12-18 2023-04-27 In2Cure Ab Composition comprising thrombin derived peptides and use thereof

Similar Documents

Publication Publication Date Title
US7348401B2 (en) Peptides that inhibit complement activation
JP6525471B2 (ja) ヘプシジン類似体及びその使用
JP6095717B2 (ja) Tfpiインヒビターおよび使用法
JP2020502051A5 (cg-RX-API-DMAC7.html)
JP2017206561A (ja) 長期間作用性ペプチド類似体のための組成物
JP2009542726A (ja) 抗菌ペプチド
JP2008101026A (ja) 殺菌性/透過性が向上したタンパク質の機能領域に由来する生物学的に活性なペプチドおよびその使用
JP2012067100A (ja) Il−21の誘導体
JP6633523B2 (ja) Psd−95の二量体阻害剤脂肪酸誘導体
JP2020526497A5 (cg-RX-API-DMAC7.html)
CA2562890A1 (en) Novel g-csf conjugates
TW202306965A (zh) Psd-95抑制劑及其用途
WO2022125606A2 (en) Peptide therapeutics for treating alzheimer's disease and related conditions
CN1867581B (zh) Il-21衍生物
WO1994013697A1 (en) Treatment of septic shock with conjugated biologically active peptides
CN115209913A (zh) 对胰高血糖素/glp-1/gip受体均具有活性的三重激动剂的长效缀合物对肺病的治疗用途
JP2024539138A (ja) 多価効果を持つペプチド
JP2022513626A5 (cg-RX-API-DMAC7.html)
JP3221881B2 (ja) C反応性タンパク質断片から誘導されたオリゴペプチド
US20260028397A1 (en) Methods of treating ankylosing spondylitis
JPH10182479A (ja) ペプチド誘導体類からなる薬剤
WO2025137159A1 (en) Human interleukin (il)-17 cytokine binding peptides
AU673332B2 (en) Peptide which abrogates TNF and/or LPS toxicity
WO2008012066A2 (en) Novel peptide having antimicrobial activity